Skip to main navigation

Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

Charles River logo on side of building
Investor Relations
  • Investor Relations Home
  • Corporate Governance
  • Corporate Citizenship
  • Investor Day 2023
  • Annual Meeting 2026
  • Stock Information
  • News Releases
  • Financial Information
  • SEC Filings
  • Presentations
  • Analyst Information
  • Calendar
  • Shareholder Services

Casey Woodring

Back

Casey Woodring


J.P. Morgan
casey.woodring@jpmchase.com
212-622-9074
    Investor Relations
    • Investor Relations Home
    • Corporate Governance
    • Corporate Citizenship
    • Investor Day 2023
    • Annual Meeting 2026
    • Stock Information
    • News Releases
    • Financial Information
    • SEC Filings
    • Presentations
    • Analyst Information
    • Calendar
    • Shareholder Services

    Stock Quote

    (common)
    Price
    Change (%)
     
    Volume
    Exchange
    Data as of 03/30/26 10:33 pm EDT
    Data Provided by Refinitiv.
    Minimum 15 minutes delayed.

    Featured Reports

    2025 Annual Report
    View PDF
    Print PDF

    Charles River Corporate Citizenship Report
    View PDF
    Print PDF

    Toolkit

    • Print Page
    • Email Page
    • RSS Feeds
    • Email Alerts
    • IR Contacts